Physician characteristics associated with treatment initiation patterns in idiopathic pulmonary fibrosis

類似資料

• Real-World Practice Patterns for Prevention and Management of Potential Adverse Events with Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis
  著者:: Wencel, Mark L., 等
  出版事項: (2018)
• Changes in Neutrophil–Lymphocyte or Platelet–Lymphocyte Ratios and Their Associations with Clinical Outcomes in Idiopathic Pulmonary Fibrosis
  著者:: Nathan, Steven D., 等
  出版事項: (2021)
• Patient and site characteristics associated with pirfenidone and nintedanib use in the United States; an analysis of idiopathic pulmonary fibrosis patients enrolled in the Pulmonary Fibrosis Foundation Patient Registry
  著者:: Holtze, Colin H., 等
  出版事項: (2020)
• A Phase 1b Study of Vismodegib with Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis
  著者:: Prasse, Antje, 等
  出版事項: (2019)
• Clinical Characteristics in Patients with Asymmetric Idiopathic Pulmonary Fibrosis
  著者:: Callahan, Sean J., 等
  出版事項: (2016)